ReviewHealth science reports2025
Update on the Seroepidemiology of Human Cystic Echinococcosis and Associated Risk Factors in Iran: A Systematic Review and Meta-Analysis.
Review in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Imaging findings of fatal embolic hemorrhagic stroke secondary to right ventricular hydatid cyst: A case report.Radiology case reports · 2026Article
- Human cystic echinococcosis transmission dynamics in Iran, 1997-2040: modeling control strategies for public health planning.Parasitology research · 2026Article
- Design and evaluation of a novel direct hemagglutination test based on a recombinant protein for diagnosis of cystic echinococcosis.Parasites & vectors · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Cystic echinococcosis (CE) poses a significant public health challenge in developing countries, including Iran. This systematic review and meta-analysis aim to enhance our understanding of CE prevalence by providing an updated assessment of the general prevalence of human CE in Iran through a comprehensive review of the literature. Methods: PubMed, Scopus, Web of Science, Google Scholar, Magiran, and Scientific Information Database (SID) databases were searched for relevant literature published between January 1990 and December 2023. All peer-reviewed original papers evaluating the seroprevalence of human CE were included. Meta-analysis was performed using a random-effects model with 95% confidence intervals (CIs). Heterogeneity among the included studies was assessed using Cochran's Results: Sixty-eight studies met the inclusion criteria. The overall seroprevalence of human CE in Iran's general population was 4% (95% CI 3%-6%). Significant differences in seropositivity to human CE were observed among age groups, urban versus rural residence, diagnostic methods, and in relation to the presence of dogs at home or on farm. Substantial heterogeneity was observed across the included studies ( Conclusion: Our findings demonstrate that CE remains prevalent in Iran, necessitating intensified health interventions and the development of targeted strategies for prevention and control. Recommendations include deworming dogs with praziquantel and vaccination of sheep with recombinant EG95 protein, removing raw offal or carcasses from the diet of dogs, hand washing, fencing of slaughterhouses with offal disposal systems, community participation for the control program and screening strategies for the diagnosis of asymptomatic cases and their timely treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.